Skip to main
PEPG
PEPG logo

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 60%
Buy 20%
Hold 0%
Sell 20%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned favorably in the biotechnology sector due to its Enhanced Delivery Oligonucleotide platform, which has demonstrated superior tissue penetration and cellular uptake in preclinical studies, suggesting significant potential for treating severe neuromuscular disorders. The company has achieved a notable 53.7% splicing correction in its therapies, significantly outperforming competitors, which bodes well for future clinical outcomes in muscle performance. Additionally, with shares currently priced around $4, there appears to be substantial upside potential contingent upon forthcoming multi-dose data demonstrating a favorable risk/benefit profile, indicative of positive investor sentiment and confidence in the company's pipeline.

Bears say

PepGen Inc. has experienced a recent decrease in its target price to $8 per share, reflecting concerns about its current valuation relative to its market cap, which appears increasingly anomalous given its promising clinical data. The company faces significant risks, including the potential failure to execute its commercial strategy or meet stakeholder expectations, which could adversely affect its share price. Additionally, the inability to secure access to capital markets may lead to delays or even termination of key development programs, further exacerbating the negative outlook on the stock.

PepGen Inc (PEPG) has been analyzed by 5 analysts, with a consensus rating of Buy. 60% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Buy based on their latest research and market trends.

According to 5 analysts, PepGen Inc (PEPG) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.